PICO Portalanswers from OpenAlex & ORCID
Lawrence Blonde
ResearcherPublications, citations & collaboration network
Lawrence Blonde is a researcher indexed in PICO Portal from OpenAlex & ORCID.
How many works does Lawrence Blonde have?
PICO Portalindexed works
Lawrence Blonde has 279 works in the PICO Portal index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Lawrence Blonde have?
PICO Portalcitation count
Lawrence Blonde has 18,063 citations in the OpenAlex counts PICO Portal stores.
What is the h-index of Lawrence Blonde?
PICO Portalh-index
Lawrence Blonde has an h-index of 61 in OpenAlex.
What is the i10-index of Lawrence Blonde?
PICO Portali10-index
Lawrence Blonde has an i10-index of 132 in OpenAlex.
What is the ORCID of Lawrence Blonde?
PICO Portalorcid
The ORCID for Lawrence Blonde is on the source record.
What is the OpenAlex record for Lawrence Blonde?
PICO Portalopenalex
The OpenAlex for Lawrence Blonde is on the source record.
What are the most-cited papers on Lawrence Blonde?
PICO Portalmost cited works
Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6)
John B. Buse, Julio Rosenstock, Giorgio Sesti, Wolfgang E. Schmidt, Eduard Montanya, Jason Brett, Marcin Zychma, Lawrence Blonde
Consensus Statement By The American Association Of Clinical Endocrinologists And American College Of Endocrinology On The Comprehensive Type 2 Diabetes Management Algorithm – 2016 EXECUTIVE SUMMARY
Alan J. Garber, Martin J. Abrahamson, Joshua I. Barzilay, Lawrence Blonde, Zachary T. Bloomgarden, Michael A. Bush, Samuel Dagogo‐Jack, Ralph A. DeFronzo, Daniel Einhorn, Vivian Fonseca, Jeffrey R. Garber, W. Timothy Garvey, George Grunberger, Yehuda Handelsman, Robert R. Henry, Irl B. Hirsch, Paul S. Jellinger, Janet B. McGill, Jeffrey I. Mechanick, Paul D. Rosenblit, Guillermo E. Umpierrez
Efficacy and Safety of the Human Glucagon-Like Peptide-1 Analog Liraglutide in Combination With Metformin and Thiazolidinedione in Patients With Type 2 Diabetes (LEAD-4 Met+TZD)
Bernard Zinman, John Gerich, John B. Buse, Andrew Lewin, Sherwyn Schwartz, Philip Raskin, Paula M. Hale, Milan Zdravkovic, Lawrence Blonde, the LEAD-4 Study Investigators
Business Information
Rodbard Hw, Lawrence Blonde, Braithwaite Ss, Elise M. Brett, Rhoda H. Cobin, Yehuda Handelsman, Richard Hellman, Paul S. Jellinger, Lois Jovanovič, Philip Levy, Jeffrey I Mechanick, Farhad Zangeneh
American Association of Clinical Endocrinologists and American College of Endocrinology – Clinical Practice Guidelines for Developing A Diabetes Mellitus Comprehensive Care Plan – 2015 — Executive Summary
Yehuda Handelsman, Zachary T. Bloomgarden, George Grunberger, Guillermo E. Umpierrez, Robert S. Zimmerman, Timothy S. Bailey, Lawrence Blonde, George A. Bray, A. Jay Cohen, Samuel Dagogo‐Jack, Jaime A. Davidson, Daniel Einhorn, Om P. Ganda, Alan J. Garber, W. Timothy Garvey, Robert R. Henry, Irl B. Hirsch, Edward S. Horton, Daniel L. Hurley, Paul S. Jellinger, Lois Jovanovič, Harold E. Lebovitz, Derek LeRoith, Philip T. Levy, Janet B. McGill, Jeffrey I. Mechanick, Jorge H. Mestman, Etie S. Moghissi, Eric A. Orzeck, Rachel Pessah‐Pollack, Paul D. Rosenblit, Aaron I. Vinik, Kathleen Wyne, Farhad Zangeneh